鶹ýӰ

Depression Trial Wins, Losses; Americans' Chronic Insomnia; Kids' Sleep Anxiety

— News and commentary from the psychiatry world

MedpageToday
Illustration of a brain shaped maze.

Another phase III trial of in patients with major depressive disorder met its endpoints, significantly reducing Montgomery-Åsberg Depression Rating Scale (MADRS) scores by week 6, said Intra-Cellular Therapies.

In other news, -- one of the two components of methadone -- flopped in a late-stage trial as adjunctive treatment in patients with major depressive disorder with inadequate response to standard antidepressants. (Journal of Clinical Psychiatry)

An American Academy of Sleep Medicine survey found 12% of Americans have been .

CDC survey data from 2022 showed that 4% of Americans ages 65 and older had ever . (National Health Statistics Reports)

In partnership with several groups including the American Psychiatric Association, the American Society of Addiction Medicine opened up the draft of its for public comment until July 19.

Early discontinuation of was linked with increased rates of readmission for patients with first-admission schizophrenia in Taiwan. (JAMA Network Open)

Disney's Inside Out 2 is . (New York Times)

One in four parents said their because of being worried or anxious, according to a C.S. Mott Children's Hospital national poll.

Traumatic brain injury was associated with higher risk of in Sweden, a link not explained by familial confounding. (Psychiatry Research)

Some men may not be able to self-identify . (The Guardian)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.